Counterfeit Medicines Volume I Policy, Economics and Countermeasures

Edited by Albert I. Wertheimer and Perry G. WangHardback

Now available as an eBook fromAmazon>>

Although there is some debate about the extent of counterfeits in the world’s pharmaceutical supply chain, it is undeniable that counterfeit and substandard medicines are a growing and dangerous business. They can cause major moral, reputational and financial damage to pharmaceutical manufacturers, as well as untold harm to patients who are deceived by the fake version of their medication.

This book provides a concise account of the history, policy and law, and financial and economic aspects surrounding pharmaceutical product counterfeiting, as well as some of the countermeasures available to organisations.

这份有价值的出版物讨论了欠发达国家所经历的问题，并报告了世界各国政府和机构的活动和调查结果。对非法网上药店的安全性问题进行了审查，并概述了试图阻止其负面影响的监管努力。该书提供了建立一个全面的反假冒战略的重要信息，并回顾了当前的对策，包括认证和跟踪规划。此外，该书还比较了其他产品领域在伪造方面遇到的一些问题，包括艺术品、葡萄酒、钻石、货币和飞机部件。

With the inclusion of economic and financial models and projections as well as real-life case studies, this book is essential reading for individuals and organisations affected by this complex issue.

Table of Contents

Chapter 1The Background and History of Counterfeit Medicines
Obinna Obi-Eyisi and Albert I. Wertheimer

Chapter 2The Current Policy and Law of Counterfeit Medicines: In Memoriam to Donald Eulette deKieffer, 1945–2011
Donald deKieffer and J. Kevin Horgan

Chapter 3The Financial and Economic Aspects of Counterfeit Medicines
F. Ellen Loh

Chapter 4The Counterfeiting of Pharmaceutical Products in Lesser Developed Countries: A Case Study of Mexico
Rafael Gual Cosio

Chapter 5The Fight Against Counterfeit and Substandard Pharmaceuticals by Governments, International Agencies and Professional Societies
Anna Gu

Chapter 6International Politics Becomes Involved in the Fight Against Counterfeit Medicines
Kawthar ElBishlawi

Chapter 7Addressing Illicit Online Pharmacies: Global Patient Safety and Regulatory Challenges
Bryan A. Liang and Tim Mackey

Chapter 8Counterfeiting in Other Industries: Lessons for Pharmaceuticals
Nazli Sencan

Chapter 9Overview of the Selection of Strategic Authentication and Tracing Programmes
John Spink

Author Biography

Professor Albert I. Wertheimer received his BS degree in Pharmacy from the University of Buffalo, New York. He earned a Master of Business Administration (MBA) from the State University of New York at Buffalo and his PhD from Purdue University in Lafayette, Indiana. He conducted post-doctoral research at the Department of Social Medicine of St Thomas’ Hospital Medical School in London. He is currently Professor of Pharmacy Economics in the Pharmacy Practice Department of Temple University School of Pharmacy in Philadelphia, Pennsylvania. He is the author or co-author of over 400 articles in scientific and professional journals, and an author or editor of 32 books. He has lectured and consulted in more than 60 countries.

Dr. Perry G. Wang received his BS degree in Chemistry from Shandong University, China. He earned his MS and PhD degrees in Environmental Engineering from Oregon State University, USA. He is currently a research chemist in the Office of Regulatory Science, Center for Food Safety and Applied Nutrition, US Food and Drug Administration (US FDA) in College Park, Maryland. His current research focuses on developing analytical methods for constituents in cosmetics and dietary supplements by GC/MS/MS and LC/MS/MS. He has edited or co-edited three books and published numerous peer-reviewed papers in drug analysis, cosmetics and food safety